Pharmacy Finance

Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how pharmacies can utilize med sync programs and what they can expect when implementing one.

During a session at AMCP Nexus 2023, presenters discussed the delicate balance between cost and innovation as it relates to forthcoming oncology treatments.

Panelists at AMCP Nexus 2023 provided a rundown of the 340B discount program and addressed whether it's actually working to lower out-of-pocket costs for patients.

Mary Stoner, president of Electronic Billing Services Inc., sat down with Drug Topics at NCPA 2023 to discuss the billing process for non-dispensing services in pharmacies.

Lisa Faast, CEO and Owner of DiversifyRx, discusses ways that pharmacists can prepare their business for the cash crunch that is set to happen in the first several months of next year.

Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN, discusses how med sync programs can help boost a pharmacy's bottom line.

In a webinar hosted by the National Community Pharmacists Association, experts from accounting agency Sykes & Company, PA discussed how pharmacies can navigate the upcoming changes.

Small Business Saturday was created by American Express in 2010 and represents an important sales opportunity for independent community pharmacies across the United States.

A Q&A with Tiffany Capps, CPhT, pharmacy operations manager at Galloway-Sands Pharmacy in North Carolina and marketing communications manager at CPESN Networks.

The class action lawsuit against CVS Health, Caremark, and Aetna was announced earlier today.

A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.

A greater number of pharmacy audits are originating not only from third party payors, but also from various government agencies, such as Medicare and Medicaid.

The Modernizing and Ensuring PBM Accountability Act, recently passed by the Senate Finance Committee, aims to regulate PBMs in the Medicare Part D, Medicare Advance, and Medicaid spaces.

New DIR fee rules eliminate clawbacks, but may create cashflow challenges for pharmacies in the first half of 2024.

Over the last 5 years, both PBMs and drug manufacturers have implemented restrictions that raise patients’ cost burden for specialty medications.

Using a national database, data on medication purchases was collected, along with factors that may have influenced expenditures, such as new therapy availability, patent expirations, policy changes, and legislation.

The average annual healthcare spending for people with employer-sponsored insurance spending increased from $5,630 in 2020 to $6,467 in 2021. After decreasing in 2020, per person healthcare spending increased 15%.

Members of the Senate Finance Committee are pushing PBMs to modernize the rules regarding out of pocket costs and competition.

Community pharmacists can provide crucial services that meet patients where they are: at home.

The advertisements are intended to provide education around the services that pharmacy benefit managers provide

Many independent pharmacies closed during the last recession.

Opening a second pharmacy location can be profitable, but isn’t without challenges.

Discount cards and manufacturer coupons can cost pharmacies in the long run.

For pharmacy owners, understanding tax code can lead to financial benefits at tax time.

Working collaboratively can be key to either avoiding a PBM audit altogether or making the process as painless as possible.

Pharmacy finances can suffer if owners are tripped up by these common pitfalls.

Quality documentation ensures that pharmacies get paid for clinical services and offers a way to engage with patients.

Changes to DIR fees are coming. Taking proactive steps can help pharmacies avoid feeling the pinch.

Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.